|
ZNF808 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64634972321664E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68298708302927E-12 |
| Normal-vs-Stage2 |
1.49249945735619E-10 |
| Normal-vs-Stage3 |
1.62891922173003E-12 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
3.029200E-01 |
| Stage1-vs-Stage3 |
2.313200E-01 |
| Stage1-vs-Stage4 |
5.278000E-03 |
| Stage2-vs-Stage3 |
6.636000E-02 |
| Stage2-vs-Stage4 |
6.138500E-03 |
| Stage3-vs-Stage4 |
1.581630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.21565038222616E-15 |
| Normal-vs-AfricanAmerican |
9.05360009184619E-10 |
| Normal-vs-Asian |
6.35913544044797E-12 |
| Caucasian-vs-AfricanAmerican |
3.011800E-01 |
| Caucasian-vs-Asian |
4.349400E-01 |
| AfricanAmerican-vs-Asian |
7.077000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.28705943072782E-14 |
| Normal-vs-Female |
2.24265050974282E-14 |
| Male-vs-Female |
8.530200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.72955008490317E-14 |
| Normal-vs-Age(41-60Yrs) |
9.43689570931383E-15 |
| Normal-vs-Age(61-80Yrs) |
4.11892742135933E-14 |
| Normal-vs-Age(81-100Yrs) |
9.480000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.752600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.970600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.992800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.242800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.066500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.771000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.33649999999264E-05 |
| Classical-VS-Follicular |
4.603400E-01 |
| Classical-VS-Other |
3.411000E-01 |
| Classical-VS-Normal |
2.02970973361971E-12 |
| Tall-VS-Follicular |
4.556800E-04 |
| Tall-VS-Other |
4.880000E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
3.506400E-01 |
| Follicular-VS-Normal |
2.51787479754739E-12 |
| Other-VS-Normal |
1.244400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.45199432874688E-14 |
| Normal-vs-N1 |
1.0547118733939E-14 |
| N0-vs-N1 |
1.099630E-01 |
|
|
